Effect of cisplatin on the transport activity of PII-type ATPases-Reference-Cited by-同舟云学术

Effect of cisplatin on the transport activity of PII-type ATPases

Published:2017 Issue:7 Volume:9 Page:960-968
ISSN:1756-5901
Container-title:Metallomics
language:en
Short-container-title:Metallomics

Author:

Tadini-Buoninsegni Francesco¹²³⁴^ORCID,Sordi Giacomo¹²³⁴,Smeazzetto Serena¹²³⁴^ORCID,Natile Giovanni⁵⁶⁷⁴^ORCID,Arnesano Fabio⁵⁶⁷⁴^ORCID

Affiliation:

1. Department of Chemistry “Ugo Schiff”

2. University of Florence

3. 50019 Sesto Fiorentino

4. Italy

5. Department of Chemistry

6. University of Bari “Aldo Moro”

7. 70125 Bari

Abstract

Cisplatin inhibits the activities of SERCA and Na⁺,K⁺-ATPase with different degrees of potency. Inhibition is reversible for Na⁺,K⁺-ATPase and irreversible for SERCA.

Funder

Ente Cassa di Risparmio di Firenze

Publisher

Oxford University Press (OUP)

Subject

Metals and Alloys,Biochemistry,Biomaterials,Biophysics,Chemistry (miscellaneous)

Link

http://pubs.rsc.org/en/content/articlepdf/2017/MT/C7MT00100B

Reference68 articles.

1. Modifications of DNA by platinum complexes

2. Direct Cellular Responses to Platinum-Induced DNA Damage

3. The resurgence of platinum-based cancer chemotherapy

4. The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

5. Platinum-based drugs: past, present and future

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cisplatin Provokes Peripheral Nociception and Neuronal Features of Therapy-Induced Senescence and Calcium Dysregulation in Rats;Neurotoxicity Research;2024-01-31

2. Troxerutin alleviates kidney injury in rats via PI3K/AKT pathway by enhancing MAP4 expression;Food & Nutrition Research;2022-05-24

3. Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation;Cardiogenetics;2022-02-07

4. Na, K-ATPase as a Biological Target for Gold(III) Complexes: A Theoretical and Experimental Approach;Current Medicinal Chemistry;2021-08-02

5. Targeting oncogenic Notch signaling with SERCA inhibitors;Journal of Hematology & Oncology;2021-01-06